FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

421716009: Prolonged-release transdermal drug delivery system (dose form)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3634515018 A dose form that is an assembly of components for transdermal delivery driven by external forces. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
    3634741014 Prolonged-release transdermal drug delivery system en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3634742019 Prolonged-release transdermal drug delivery system (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    164801000077111 système transdermique d'administration de médicaments fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    système transdermique d'administration de médicaments Is a forme pharmaceutique d'un médicament false Inferred relationship Some
    système transdermique d'administration de médicaments Is a forme pharmaceutique pour usage transdermique et/ou cutané false Inferred relationship Some
    système transdermique d'administration de médicaments Is a Transdermal dose form (dose form) false Inferred relationship Some
    système transdermique d'administration de médicaments Has dose form administration method (attribute) A method of administration of a dose form by placing or spreading on a body surface. false Inferred relationship Some
    système transdermique d'administration de médicaments Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration to the skin in order to obtain an effect after absorption through the skin barrier. false Inferred relationship Some
    système transdermique d'administration de médicaments Has dose form release characteristic (attribute) A release characteristic where a dose form displays a slower release of the active substance(s) than that of a conventional-release dose form. This may be achieved by a special formulation design, manufacturing process or other methods. false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing scopolamine hydrobromide in transdermal dosage form Has manufactured dose form False système transdermique d'administration de médicaments Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start